Trial of 6% HES130/0.4

PHASE3CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

November 30, 2010

Conditions
HypovolemiaHemorrhage
Interventions
DRUG

6% hydroxyethyl starch 130/0.4

Up to 1000mL 6% hydroxyethyl starch 130/0.4 solution i.v., intra-operatively (from start of surgery until end of surgery)

DRUG

6% hydroxyethyl starch 70/0.5 (Salinhes®)

Up to 1000mL 6% hydroxyethyl starch 70/0.5 (Salinhes®) solution i.v., intra-operatively (from start of surgery until end of surgery)

Trial Locations (7)

060-8543

Sapporo Medical University, School of Medicine, Sapporo

812-8582

Kyushu University, Graduate School of Medical Sciences, Fukuoka

650-0017

Kobe University Graduate School of Medicine, Kobe

700-8558

Okayama University, Okayama

565-0871

Osaka University Graduate School of Medicine, Osaka

160-8582

Keio University School of Medicine, Tokyo

162-8666

Tokyo Women's Medical University, Tokyo

Sponsors
All Listed Sponsors
lead

Fresenius Kabi Japan

INDUSTRY